Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Naggi

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
International Journal of Clinical Pharmacology and Therapeutics|June 19, 2010
Blocking of integrin-mediated human MV3 melanoma cell binding by commercial and modified heparinsM Schlesinger, A Naggi, G Torri, et al.
Thrombosis and Haemostasis|September 7, 2013
Cyr61 is a target for heparin in reducing MV3 melanoma cell adhesion and migration via the integrin VLA-4P Schmitz, U Gerber, N Schütze, et al.
Journal of Chromatography|September 24, 1993
Characterization of the chemical structure of sulphated glycosaminoglycans after enzymatic digestion. Application of liquid chromatography-mass spectrometry with an atmospheric pressure interfaceR Da Col, L Silvestro, A Naggi, et al.
Thrombosis and Haemostasis|October 1, 1995
Differentiation of beef and pig mucosal heparins by NMR spectroscopyB Casu, M Guerrini, A Naggi, et al.
Lancet (London, England)|May 9, 1987
Bleeding associated with heparin contaminantsB Casu, A Naggi, P Oreste, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1994
Nuclear magnetic resonance analysis of human urine: influence of intravenous and oral administration of glycosaminoglycansG Torri, A Bisio, B Casu, et al.
Carbohydrate Research|October 17, 1994
Heparin-like compounds prepared by chemical modification of capsular polysaccharide from E. coli K5B Casu, G Grazioli, N Razi, et al.
Biochemical Pharmacology|June 15, 1987
"Supersulfated" heparin fragments, a new type of low-molecular weight heparin. Physico-chemical and pharmacological propertiesA Naggi, G Torri, B Casu, et al.
Carbohydrate Research|November 22, 2000
Effect of substitution pattern on 1H, 13C NMR chemical shifts and 1J(CH) coupling constants in heparin derivativesE A Yates, F Santini, B De Cristofano, et al.
Molecular and Cellular Biochemistry|December 29, 2000
Influence of glucose on production and N-sulfation of heparan sulfate in cultured adipocyte cellsN Parthasarathy, L F Gotow, J D Bottoms, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
International Journal of Clinical Pharmacology and Therapeutics|June 19, 2010
Blocking of integrin-mediated human MV3 melanoma cell binding by commercial and modified heparinsM Schlesinger, A Naggi, G Torri, et al.
Thrombosis and Haemostasis|September 7, 2013
Cyr61 is a target for heparin in reducing MV3 melanoma cell adhesion and migration via the integrin VLA-4P Schmitz, U Gerber, N Schütze, et al.
Journal of Chromatography|September 24, 1993
Characterization of the chemical structure of sulphated glycosaminoglycans after enzymatic digestion. Application of liquid chromatography-mass spectrometry with an atmospheric pressure interfaceR Da Col, L Silvestro, A Naggi, et al.
Thrombosis and Haemostasis|October 1, 1995
Differentiation of beef and pig mucosal heparins by NMR spectroscopyB Casu, M Guerrini, A Naggi, et al.
Lancet (London, England)|May 9, 1987
Bleeding associated with heparin contaminantsB Casu, A Naggi, P Oreste, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1994
Nuclear magnetic resonance analysis of human urine: influence of intravenous and oral administration of glycosaminoglycansG Torri, A Bisio, B Casu, et al.
Carbohydrate Research|October 17, 1994
Heparin-like compounds prepared by chemical modification of capsular polysaccharide from E. coli K5B Casu, G Grazioli, N Razi, et al.
Biochemical Pharmacology|June 15, 1987
"Supersulfated" heparin fragments, a new type of low-molecular weight heparin. Physico-chemical and pharmacological propertiesA Naggi, G Torri, B Casu, et al.
Carbohydrate Research|November 22, 2000
Effect of substitution pattern on 1H, 13C NMR chemical shifts and 1J(CH) coupling constants in heparin derivativesE A Yates, F Santini, B De Cristofano, et al.
Molecular and Cellular Biochemistry|December 29, 2000
Influence of glucose on production and N-sulfation of heparan sulfate in cultured adipocyte cellsN Parthasarathy, L F Gotow, J D Bottoms, et al.
Pageof 4